Company: MDXG
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001376339-25-000009
Chunk: 4

Company: MIMEDX GROUP, INC.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 4
---
QUITYCurrent liabilities: Current portion of long term debt$1,000 $1,000 Accounts payable7,409 9,048 Accrued compensation23,667 22,353 Accrued expenses9,012 9,361 Current portion of Profit Share Payments1,421 — Current liabilities of discontinued operations— 1,352 Other current liabilities3,086 2,894 Total current liabilities45,595 46,008 Long term debt, net17,830 48,099 Other liabilities7,383 2,223 Total liabilities$70,808 $96,330 Commitments and contingencies (Note 18)Stockholders’ equityCommon stock; $.001 par value; 250,000,000 shares authorized, 146,932,032 issued and outstanding at December 31, 2024 and 146,227,639 issued and outstanding at December 31, 2023147 146Additional paid-in capital284,219 276,249 Accumulated deficit(91,259)(133,678)Total stockholders’ equity193,107 142,717 Total liabilities and stockholders’ equity$263,915 $239,047 

 See notes to the consolidated financial statements.

F- 4

MIMEDX GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

 Year Ended December 31, 202420232022Net sales$348,879 $321,477 $267,841 Cost of sales60,073 54,634 48,316 Gross profit288,806 266,843 219,525 Operating expenses:  Selling, general and administrative225,087 211,124 208,673 Research and development12,341 12,665 12,701 Investigation, restatement and related(8,698)5,176 12,177 Amortization of intangible assets765 762 701 Impairment of intangible assets446 — — Operating income (loss)58,865 37,116 (14,727)Other expense, net  Interest expense, net(1,006)(6,457)(5,016)Other expense, net(565)(26)(4)Income (loss) from continuing operations before